Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Vanderbilt-Ingram Cancer Center
NRG Oncology
University of Arizona
Rigshospitalet, Denmark